Summary by Futu AI
China Traditional Chinese Medicine Holdings Co., Ltd. ("trad chi med") held its annual general meeting of shareholders on June 14, 2024, and all proposed resolutions were passed by the shareholders. These resolutions include the review and approval of the financial statements, board of directors' report and independent auditor's report for the year ended December 31, 2023, as well as the re-election of multiple directors, and authorization of the board of directors to determine director's remuneration. In addition, Ernst & Young was reappointed as the company's auditor and authorized the board of directors to determine its compensation. The directors present at the annual general meeting included Executive Director Mr. Chen Yinglong, Non-executive Director Mr. Cheng Xueren, and Independent Non-executive Directors Mr. Xie Rong, Mr. Yu Zishan, Mr. Qin Ling and Mr. Li Weidong. Hong Kong Central Clearing and Settlement Company Limited served as the scrutineer and was responsible for counting the votes. As of the date of the meeting, the total number of issued shares of the company was 5,035,801,852 shares.